anti-CTGF RNAi sd-rxRNA (RXi Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Nameanti-CTGF RNAi sd-rxRNA (RXi Pharmaceuticals)

Drug Alias Nameanti-connective tissue growth factor RNAi sd-rxRNA (RXi Pharmaceuticals)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionConnective tissue growth factor inhibitorsVascular endothelial growth factor inhibitors

TargetsVascular endothelial growth factorConnective tissue growth factor

Therapy Area/IndicationsOcular fibrosisMacular DegenerationRetinal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPhio Pharmaceuticals Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPhio Pharmaceuticals Corp

Active IndicationsN/A

Inactive IndicationsOcular fibrosisMacular DegenerationRetinal Diseases

Other Information

ATC CodeN/A